Biocomputing 2017 2016
DOI: 10.1142/9789813207813_0033
|View full text |Cite
|
Sign up to set email alerts
|

Precision Medicine: Data and Discovery for Improved Health and Therapy

Abstract: The major goal of precision medicine is to improve human health. A feature that unites much research in the field is the use of large datasets such as genomic data and electronic health records. Research in this field includes examination of variation in the core bases of DNA and their methylation status, through variations in metabolic and signaling molecules, all the way up to broader systems level changes in physiology and disease presentation. Intermediate goals include understanding the individual drivers… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 33 publications
0
3
0
Order By: Relevance
“…The European Union has acknowledged the importance of personalized medicine by issuing two policy papers arguing in favor of a broader use of personalized medicine (focusing on cancer diagnostics or therapeutics in particular) [ 335 , 336 ], while remarking that such a goal may be hampered by the still high degree of uncertainty surrounding the outcomes [ 337 ]. The key factor that can enable and unleash the full potential of personalized medicine is, according to the analysis laid out in the EU papers, an effective synergy between health data and new technologies, which is necessary to pave the way for the beneficial development of personalized medicine [ 338 ]. We can rely on its unique potential to confront cancer by means of prevention and treatment strategies enabling patients to receive the therapies that can ultimately work best for them.…”
Section: Ethical Legal and Social Issues Of Personalized Medicinementioning
confidence: 99%
“…The European Union has acknowledged the importance of personalized medicine by issuing two policy papers arguing in favor of a broader use of personalized medicine (focusing on cancer diagnostics or therapeutics in particular) [ 335 , 336 ], while remarking that such a goal may be hampered by the still high degree of uncertainty surrounding the outcomes [ 337 ]. The key factor that can enable and unleash the full potential of personalized medicine is, according to the analysis laid out in the EU papers, an effective synergy between health data and new technologies, which is necessary to pave the way for the beneficial development of personalized medicine [ 338 ]. We can rely on its unique potential to confront cancer by means of prevention and treatment strategies enabling patients to receive the therapies that can ultimately work best for them.…”
Section: Ethical Legal and Social Issues Of Personalized Medicinementioning
confidence: 99%
“…symptoms over a disease course. The associations are often statistically concluded from the evidence collected from the clinical records [ 1 ]. The medical big data mostly exists in an unstructured form, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…This is done by applying emerging methodologies in epidemiology, biostatistics, and computing systems, including machine learning and artificial intelligence. These concepts often intersect, where clinical guidelines developed from population-level studies are adjusted to an individual patient based on their unique characteristics, leading to optimal care [3].…”
Section: Introductionmentioning
confidence: 99%